Drugs / TIL
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03166397 | Jun 2017 → Jan 2025 | metastatic melanoma | Sheba Medical Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03166397 ↗ |
| Modality | Cell therapy | “ex-vivo expanded autologous TIL as the Investigational Product (IP)” NCT03166397 ↗ |